Evidence map›Paper›PMID 25126759›Full record

ArticlePloS one2014

Aqueous leaf extract of Jatropha gossypiifolia L. (Euphorbiaceae) inhibits enzymatic and biological actions of Bothrops jararaca snake venom.

Juliana Félix-Silva, Thiago Souza, Yamara A S Menezes, Bárbara Cabral, Rafael B G Câmara, Arnóbio A Silva-Junior, Hugo A O Rocha, Ivanise M M Rebecchi, Silvana M Zucolotto, Matheus F Fernandes-Pedrosa

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2020
    Article
  7. Article
  8. Ethnopharmacology Study of Plants from Atlantic Forest with Leishmanicidal Activity.Evidence-based complementary and alternative medicine : eCAM · 2019
    Article
  9. Article
  10. Pharmacological Properties ofAdvanced pharmaceutical bulletin · 2017
    Article
  11. Article
  12. Evidence forJournal of venom research · 2017
    Article
  13. Review
  14. Anti-Inflammatory and Antibothropic Properties ofAdvanced pharmaceutical bulletin · 2016
    Article
  15. A Review on Medicinal Properties of Orientin.Advances in pharmacological sciences · 2016
    Review
  16. Article
  17. Aqueous Leaf Extract ofBioMed research international · 2016
    Article
  18. Article
  19. Potential use ofIndian journal of pharmacology
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Juliana Félix-SilvaLaboratório de Tecnologia & Biotecnologia Farmacêutica (TecBioFar), Programa de Pós-graduação em Ciências Farmacêuticas (PPgCF), Universidade Federal do Rio Grande do Norte (UFRN), Natal, Rio Grande do Norte, Brazil.
Thiago SouzaLaboratório de Tecnologia & Biotecnologia Farmacêutica (TecBioFar), Programa de Pós-graduação em Ciências Farmacêuticas (PPgCF), Universidade Federal do Rio Grande do Norte (UFRN), Natal, Rio Grande do Norte, Brazil.
Yamara A S MenezesLaboratório de Tecnologia & Biotecnologia Farmacêutica (TecBioFar), Programa de Pós-graduação em Ciências Farmacêuticas (PPgCF), Universidade Federal do Rio Grande do Norte (UFRN), Natal, Rio Grande do Norte, Brazil.
Bárbara CabralLaboratório de Farmacognosia, Departamento de Farmácia, Universidade Federal do Rio Grande do Norte (UFRN), Natal, Rio Grande do Norte, Brazil.
Rafael B G CâmaraLaboratório de Biotecnologia de Polímeros Naturais (BIOPOL), Programa de Pós-graduação em Bioquímica, Universidade Federal do Rio Grande do Norte (UFRN), Natal, Rio Grande do Norte, Brazil.
Arnóbio A Silva-JuniorLaboratório de Tecnologia & Biotecnologia Farmacêutica (TecBioFar), Programa de Pós-graduação em Ciências Farmacêuticas (PPgCF), Universidade Federal do Rio Grande do Norte (UFRN), Natal, Rio Grande do Norte, Brazil.
Hugo A O RochaLaboratório de Biotecnologia de Polímeros Naturais (BIOPOL), Programa de Pós-graduação em Bioquímica, Universidade Federal do Rio Grande do Norte (UFRN), Natal, Rio Grande do Norte, Brazil.
Ivanise M M RebecchiLaboratório de Hematologia Clínica, Departamento de Análises Clínicas e Toxicológicas, Universidade Federal do Rio Grande do Norte (UFRN), Natal, Rio Grande do Norte, Brazil.
Silvana M ZucolottoLaboratório de Farmacognosia, Departamento de Farmácia, Universidade Federal do Rio Grande do Norte (UFRN), Natal, Rio Grande do Norte, Brazil.
Matheus F Fernandes-PedrosaLaboratório de Tecnologia & Biotecnologia Farmacêutica (TecBioFar), Programa de Pós-graduação em Ciências Farmacêuticas (PPgCF), Universidade Federal do Rio Grande do Norte (UFRN), Natal, Rio Grande do Norte, Brazil.
Universidade Federal do Rio Grande do Norte · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Snakebites are a serious public health problem due their high morbi-mortality. The main available specific treatment is the antivenom serum therapy, which has some disadvantages, such as poor neutralization of local effects, risk of immunological reactions, high cost and difficult access in some regions. In this context, the search for alternative therapies is relevant. Therefore, the aim of this study was to evaluate the antiophidic properties of Jatropha gossypiifolia, a medicinal plant used in folk medicine to treat snakebites. The aqueous leaf extract of the plant was prepared by decoction and phytochemical analysis revealed the presence of sugars, alkaloids, flavonoids, tannins, terpenes and/or steroids and proteins. The extract was able to inhibit enzymatic and biologic activities induced by Bothrops jararaca snake venom in vitro and in vivo. The blood incoagulability was efficiently inhibited by the extract by oral route. The hemorrhagic and edematogenic local effects were also inhibited, the former by up to 56% and the latter by 100%, in animals treated with extract by oral and intraperitoneal routes, respectively. The inhibition of myotoxic action of B. jararaca reached almost 100%. According to enzymatic tests performed, it is possible to suggest that the antiophidic activity may be due an inhibitory action upon snake venom metalloproteinases (SVMPs) and/or serine proteinases (SVSPs), including fibrinogenolytic enzymes, clotting factors activators and thrombin like enzymes (SVTLEs), as well upon catalytically inactive phospholipases A2 (Lys49 PLA2). Anti-inflammatory activity, at least partially, could also be related to the inhibition of local effects. Additionally, protein precipitating and antioxidant activities may also be important features contributing to the activity presented. In conclusion, the results demonstrate the potential antiophidic activity of J. gossypiifolia extract, including its significant action upon local effects, suggesting that it may be used as a new source of bioactive molecules against bothropic venom.

Indexed as

BothropsAdultAnimalsAnticoagulantsAntidotesAntioxidantsBlood CoagulationCrotalid VenomsEuphorbiaceaeHEK293 CellsHumansMicePlant ExtractsPlant LeavesAnticoagulantsAntidotesAntioxidantsCrotalid VenomsPlant Extracts

Identifiers

PMID25126759
PMCPMC4134247
OpenAlexW2036787724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.